Three (37.5%) out of the eight cases of invasive ductal carcinoma with adjacent in situ ductal component revealed positive MMP-9 expression in the in situ carcinoma lesions (Figure 2c) while the rest of the cases showed negative expression (Figure 2d). The gene discussed is MMP9; the disease is in situ carcinoma.